* Onyx Pharmaceuticals Inc., of Richmond, Calif., appointed AllanBalmain vice president of research.

* Ostex International Inc., of Seattle, named Robert Littauer seniorvice president and chief financial officer and Jeffrey Miller seniorvice president of corporate development.

* Peptide Therapeutics Group plc, of Cambridge, U.K., named NickHiggins to the company's board as licensing director.

* Shaman Pharmaceuticals Inc., of South San Francisco, appointedPeter O'Hanley, on leave from Stanford University School ofMedicine, consultant for the company's Phase II trial of Provir.

* Sparta Pharmaceuticals Inc., of Horsham, Pa., named to its board ofdirectors Colin Bier, managing director of ABA BioResearch.

* Theratechnologies, of Montreal, named as chairman Jean deGrandpre and Andre de Villers president and general manager.

* Tularik Inc., of South San Francisco, named William Rieflin vicepresident, general counsel and secretary.

(c) 1997 American Health Consultants. All rights reserved.